New JGH lab launched to test potentially revolutionary cancer treatment
A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.
A year with COVID-19: The therapeutic pipeline
Dr. Stephen Robbins, new Director of the Lady Davis Institute, and Dr. Donna Senger, of the LDI’s Cancer Axis, have received up to $6.7 million in federal support for a drug candidate that could bring relief to hospitalized patients with a severe case of COVID-19.
Telehealth plays key role in Radiation Oncology, even though treatment is provided in person
Although radiation therapy for cancer must be administered in person, the Division of Radiation Oncology is making extensive use of telehealth to provide support to patients and keep staff in the loop.
Mandate renewed for Canada-wide drug safety consortium based at the LDI
A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.